PTPN11 and neoplasm: This is important because the SHP2 inhibitor SHP099 can directly block endothelial cell proliferation, inhibit tumor neovascularization, induce tumor vessel involution, and promote vascular leakage, outcomes that differ from the effects of silencing SHP2 in the tumor cells (11).